Weak Listing: Godavari Biorefineries Makes A Lacklustre Debut, Lists At 12% Discount From IPO Price

The shares of Godavari Biorefineries Limited made a disappointing debut on the stock exchanges on Wednesday, October 30, opening at Rs 308 on the NSE-a 12.5% discount compared to its IPO price of Rs 352 per share. On the BSE, the stock began trading at Rs 310.55, marking an 11.78% decrease from the IPO issue price.

IPO Overview

The Godavari Biorefineries IPO, valued at Rs 554.75 crore, was open for subscription from October 23 to October 25. The price range for the public issue was set between Rs 334 and Rs 352 per share. The IPO witnessed robust interest from investors, receiving 1.76 times the number of bids over the shares offered. A total of 2.06 crore shares were bid for against an issue size of 1.10 crore shares.

Breaking down the subscription demand further, the retail investor segment subscribed 1.76 times, indicating strong interest from smaller investors. The Qualified Institutional Buyers (QIB) category, which typically consists of large financial institutions, subscribed at a higher rate of 2.76 times, signalling strong institutional interest. However, the Non-Institutional Investors (NII) category witnessed a lower subscription rate, coming in at just 0.93 times.

Details of the IPO Structure

The Godavari Biorefineries IPO consisted of a fresh issue of 0.92 crore shares, raising Rs 325 crore, along with an offer for sale (OFS) of 0.65 crore shares worth Rs 229.75 crore. The company had already raised Rs 166.42 crore from anchor investors on October 22, 2024.

Retail investors had the opportunity to subscribe with a minimum lot size of 42 shares, requiring a minimum investment of Rs 14,784. Equirus Capital Private Limited and SBI Capital Markets Limited served as the book-running lead managers, while Link Intime India Private Ltd handled registrar responsibilities for the issue.

The funds raised through the IPO are earmarked for several strategic goals. These include repaying or pre-paying a portion of outstanding debts, which will help the company reduce its financial burden, and supporting general corporate activities.

About Godavari Biorefineries

Founded in 1956, Godavari Biorefineries Limited has carved a niche for itself as a producer of ethanol-derived chemicals, operating one of India's largest integrated biorefineries. As of June 30, 2024, the company had a sizable ethanol production capacity of 570 KLPD, underscoring its position as a leading ethanol producer. By March 31, 2024, Godavari Biorefineries had become the world's largest producer of MPO by installed capacity, one of only two global manufacturers of natural 1,3-butanediol, and the sole producer of bio ethyl acetate in India.

The company's product range spans bio-based chemicals, multiple ethanol grades, sugar, and power. These offerings serve diverse sectors including food, beverages, pharmaceuticals, flavours and fragrances, power, fuel, personal care, and cosmetics.

Financial Performance and Outlook

Despite its standing in the market, Godavari Biorefineries has faced challenges on the financial front. Between the fiscal years ending March 31, 2023, and March 31, 2024, the company's revenue declined by 15.92%, reflecting market pressures and perhaps increasing competition. Additionally, its profit after tax (PAT) dropped by 37.37%, indicating that operational costs and other factors weighed on its bottom line.

The underwhelming listing performance of Godavari Biorefineries comes despite the strong investor demand seen during the IPO subscription period. This could reflect broader market uncertainties or investors' focus on near-term earnings potential, which was impacted by the recent decline in revenue and PAT. The negative opening could also be influenced by overall market conditions, which can often sway listing-day performance.